Prescriber Insights: APRN

Commentary: Systemic Effects of Ophthalmic Beta-Blockers March 2010

Commentary: Brand Name Extensions, Reformulations, and Labeling Revisions of OTC Products October 2009

Article: Claritin Eye and Zyrtec Itchy Eye Drops don't contain the active ingredient that you'd expect October 2009

Article: supplements to help prevent or slow age-related macular degeneration (AMD) July 2009

Article: new ophthalmic quinolone called Besivance July 2009

Other: Natural Medicines in the Clinical Management of Eye Disorders July 2009

Commentary: Age-Related Macular Degeneration: An Update July 2009

Commentary: New Drug: Besivance (Besifloxacin Ophthalmic Suspension 0.6%) July 2009

Article: Latisse (la-TEECE) will be the first drug approved for increasing eyelash growth February 2009

Article: drugs that require eye exams to rule out adverse effects on the eyes January 2009

Article: Macugen (pegaptanib), the latest treatment for "wet" age-related macular degeneration March 2005

Article: Five different drug classes are now available for glaucoma January 1999

Article: more emphasis on glaucoma testing and treatment January 1999

Other: Glaucoma Disease Review January 1999